Hepatitis A Vaccine
Hepatitis A vaccine does not promote atherogenesis in murine model
Published in Vaccine Weekly, January 7th, 2004
According to recent research from the United States, "Our laboratory demonstrated that seropositivity to hepatitis A virus (HAV) independently predicts risk for coronary artery disease (CAD). As these findings are based only on the presence of HAV-specific antibodies and not infectious virus, this prompted questions regarding possible effects of HAV vaccines on CAD development."
"If seropositivity to HAV alone, resulting from HAV vaccination, leads to increased atherogenesis, this raises important issues regarding the benefit of protection against HAV infection vs the risk of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-01-07)
More Articles from Vaccine Weekly
- Candidiasis
Anti-idiotypic antibody fragment effective against candidiasis - Breast Cancer
Chemotherapy advance reported for women with node-positive early breast cancer - Breast Cancer
Data from Theratope Vaccine trial presented - Cancer Vaccine
Tumor growth inhibited by vaccination with Her-2/neu peptides - Cancer Vaccine
Vaccines for leukemia therapy reviewed - Colon Cancer
Dendritic cell vaccine to be used in trial for new cancer treatment - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
